MTOR and cancer: In 2014, Shao et al. carried out a meta-analysis of mTOR rs2295080 containing five case–control studies [27,28,31,32,39] and reported a potential link between the wild-type TT genotype of the rs2295080 polymorphism and reduced cancer susceptibility under the dominant model [13].